MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma.
MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma.
复制标题
MOF 通过乙酰化酶活性上调肝细胞癌中雌激素受体 α 信号通路
DOI:
10.1111/cas.14836
复制
发表时间:
2021-05
期刊:
影响因子:
5.7
通讯作者:
Zhao Y
中科院分区:
文献类型:
--
作者:
Wei S;Liu W;Sun N;Wu Y;Song H;Wang C;Wang S;Zou R;Lin L;Zeng K;Zhou B;Wang M;Luan R;Yang F;Zhao Y
The histone acetyltransferase MOF (KAT8) is mainly involved in the acetylation of histone H4 at lysine 16 (H4K16) and some non‐histone proteins. The MOF expression level is significantly reduced in many cancers, however the biological function of MOF and its underlying mechanism are still elusive in hepatocellular carcinoma (HCC). Estrogen receptor α (ERα) has been considered as a tumor suppressor in HCC. Here, we demonstrated that MOF expression is significantly reduced in HCC samples, and is positively correlated with that of ERα. MOF interacts with ERα, and participates in acetylation of ERα at K266, K268, K299, thereby inhibiting ERα ubiquitination to maintain the stability of ERα. In addition, MOF participates in the upregulation of ERα‐mediated transactivation. Depletion of MOF significantly promotes cell growth, migration, and invasion in HCC cell lines. Taken together, our results provide new insights to understand the mechanism underlying the modulation function of MOF on ERα action in HCC, suggesting that MOF might be a potential therapeutic target for HCC. In summary, we have demonstrated that MOF as a crucial histone acetylase participates in the acetylation of ERα, thereby inhibiting the ubiquitination of ERα to stabilize ERα protein in HCC. MOF upregulates ERα‐induced transactivation. MOF depletion promotes the cell proliferation, migration, and invasion in HCC cells.